Pediatric inflatable bouncer-related injuries in the United States, 1990-2010

Meghan C Thompson1, Thiphalak Chounthirath, Huiyun Xiang

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA.

Pediatrics
|November 28, 2012
PubMed

Insights

Pediatric inflatable bouncer injuries treated in US emergency departments surged by 15-fold between 1990 and 2010. This trend highlights the urgent need for safety guidelines and improved bouncer designs to protect children.

Area of Science:

  • Pediatric emergency medicine
  • Injury prevention science
  • Consumer product safety

Background:

  • Inflatable bouncers are popular recreational devices for children.
  • There is a growing concern regarding the safety of inflatable bouncers.
  • Previous research has not fully captured the scope of inflatable bouncer-related injuries.

Purpose of the Study:

  • To investigate the incidence and characteristics of inflatable bouncer-related injuries among children in the United States.
  • To analyze trends in these injuries over a 21-year period.
  • To identify risk factors and injury patterns associated with inflatable bouncers.

Main Methods:

  • Utilized data from the National Electronic Injury Surveillance System (NEISS).
  • Analyzed records for patients aged 17 years and younger treated in US emergency departments (EDs).
  • Focused on injuries sustained from inflatable bouncers between 1990 and 2010.

Main Results:

  • An estimated 64,657 children were treated for inflatable bouncer injuries from 1990-2010.
  • A significant 15-fold increase in injuries occurred from 1995-2010, with rates more than doubling between 2008-2010.
  • Common injuries included fractures and strains/sprains, primarily affecting the extremities; most incidents occurred at sports/recreation locations or homes.

Conclusions:

  • The incidence of pediatric inflatable bouncer injuries has risen sharply, mirroring trends seen with trampoline injuries.
  • There is a critical need for enhanced safety guidelines and improved bouncer designs.
  • Proactive measures are essential to mitigate the risk of these preventable injuries in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...